Blue Trust Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.13K | Hold |
9
| – | – | ﹤0.01% | 2234 |
|
2025
Q1 | $995 | Sell |
9
-69
| -88% | -$7.63K | ﹤0.01% | 2294 |
|
2024
Q4 | $10.6K | Sell |
78
-270
| -78% | -$36.9K | ﹤0.01% | 1814 |
|
2024
Q3 | $47.9K | Buy |
348
+220
| +172% | +$30.3K | ﹤0.01% | 1584 |
|
2024
Q2 | $17.7K | Buy |
128
+79
| +161% | +$10.9K | ﹤0.01% | 1716 |
|
2024
Q1 | $6.76K | Buy |
49
+5
| +11% | +$690 | ﹤0.01% | 1558 |
|
2023
Q4 | $5K | Buy |
44
+28
| +175% | +$3.18K | ﹤0.01% | 1851 |
|
2023
Q3 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 1827 |
|
2023
Q2 | – | Sell |
-30
| Closed | -$4K | – | 2354 |
|
2023
Q1 | $4K | Buy |
30
+12
| +67% | +$1.6K | ﹤0.01% | 1851 |
|
2022
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 1942 |
|
2022
Q3 | $2K | Buy |
18
+5
| +38% | +$556 | ﹤0.01% | 1805 |
|
2022
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1802 |
|